Postmortem findings in a patient with cerebral amyloid angiopathy actively treated with corticosteroid

Amyloid

Volumn 19, Issue 1, 2012, Pages 47-52

  MacHida, Kazuko ^a   Tsuchiya Suzuki, Ayako ^a   Sano, Kenji ^a   Arima, Kunimasa ^b   Saito, Yuko ^b   Kametani, Fuyuki ^c   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Center Hospital of Neurology and Psychiatry   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

A amyloid; Cerebral amyloid angiopathy; Cerebrovascular amyloidosis; Corticosteroid; Regression of amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; APOLIPOPROTEIN E; DEXAMETHASONE; PREDNISOLONE;

AGED; APATHY; ARTICLE; AUTOPSY; BRAIN BIOPSY; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CAUSE OF DEATH; CELL INFILTRATION; COGNITIVE DEFECT; COMMUNICATING HYDROCEPHALUS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEPTOMENINX; LEUKOENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; PRIORITY JOURNAL; SEPSIS; SUBARACHNOID HEMORRHAGE; VASCULAR AMYLOIDOSIS; WHITE MATTER;

AGED; CEREBRAL AMYLOID ANGIOPATHY; DEXAMETHASONE; FATAL OUTCOME; FEMALE; FRONTAL LOBE; GLUCOCORTICOIDS; HUMANS;

EID: 84857218838     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.648288     Document Type: Article

References (28)

1. Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 2005;110:345-359. (Pubitemid 41672180)
2. Imaoka K, Kobayashi S, Fujihara S, Shimode K, Nagasaki M. Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitative and morphometric study. J Neurol 1999;246:661-666. (Pubitemid 29417846)
3. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, Greenberg SM, Smith EE. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 2006;67:83-87. (Pubitemid 44305466)
4. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004;55:250-256. (Pubitemid 38167002)
5. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, Greenberg SM. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007;68:1411-1416. (Pubitemid 46661556)
6. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, et al. A β-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005;128:500-515. (Pubitemid 40380186)
7. Harkness KA, Coles A, Pohl U, Xuereb JH, Baron JC, Lennox GG. Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol 2004;11:59-62. (Pubitemid 38174924)
8. Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, et al. Consequence of Aβ immunization on the vasculature of human Alzheimers disease brain. Brain 2008;131:3299-3310.
9. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, et al. Long-term effects of Aβ42 immunisation in Alzheimers disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008;372:216-223. (Pubitemid 351978111)
10. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 2003;9:448-452. (Pubitemid 36460079)
11. Machida K, Tojo K, Naito KS, Gono T, Nakata Y, Ikeda S. Cortical petechial hemorrhage, subarachnoid hemorrhage and corticosteroidresponsive leukoencephalopathy in a patient with cerebral amyloid angiopathy. Amyloid 2008;15:60-64. (Pubitemid 351238489)
12. Ishii W, Matsuda M, Nakamura N, Katsumata S, Toriumi H, Suzuki A, Ikeda S. Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med 2003;42:400-405. (Pubitemid 36701562)
13. Hazenberg BP, Limburg PC, Bijzet J, van Rijswijk MH. A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis. Ann Rheum Dis 1999;58:96-102. (Pubitemid 29116309)
14. Glenner GG, Wong CW. Alzheimers disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-890. (Pubitemid 14104991)
15. Maruyama K, Kametani F, Ikeda S, Ishihara T, Yanagisawa N. Characterization of amyloid fibril protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for both β protein and cystatin C. Neurosci Lett 1992;144:38-42.
16. Kametani F. Secretion of long Aβ-related peptides processed at epsilon- cleavage site is dependent on the ?-secretase pre-cutting. FEBS Lett 2004;570:73-76. (Pubitemid 38900959)
17. Hirohata M, Yoshita M, Ishida C, Ikeda SI, Tamaoka A, Kuzuhara S, Shoji M, et al. Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Eur J Neurol 2010;17:823-829.
18. Oide T, Takahashi H, Yutani C, Ishihara T, Ikeda S. Relationship between lobar intracerebral hemorrhage and leukoencephalopathy associated with cerebral amyloid angiopathy: clinicopathological study of 64 Japanese patients. Amyloid 2003;10:136-143. (Pubitemid 37372396)
19. Ohshima T, Endo T, Nukui H, Ikeda S, Allsop D, Onaya T. Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage. Stroke 1990;21:480-483. (Pubitemid 20089800)
20. McHugh JC, Ryan AM, Lynch T, Dempsey E, Stack J, Farrell MA, Kelly PJ. Steroid-responsive recurrent encephalopathy in a patient with cerebral amyloid angiopathy. Cerebrovasc Dis 2007;23:66-69. (Pubitemid 46112804)
21. DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, Galimberti G, et al. Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology 2011;76:842-844.
22. Hermann DM, Keyvani K, van de Nes J, Weimar C, Wiltfang J, Nitsch RM, Szodorai A. Brain-reactive β-amyloid antibodies in primary CNS angiitis with cerebral amyloid angiopathy. Neurology 2011;77:503-505.
23. Glenner GG, Henry JH, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimers degeneration. Ann Pathol 1981;1:120-129. (Pubitemid 11007222)
24. Ikeda K, Haga C, Kosaka K, Oyanagi S. Senile plaque-like structures: observation of a probably unknown type of senile plaque by periodic-acid methenamine silver (PAM) electron microscopy. Acta Neuropathol 1989;78:137-142. (Pubitemid 19160916)
25. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983;14:924-928. (Pubitemid 14205243)
26. Cosgrove GR, Leblanc R, Meagher-Villemure K, Ethier R. Cerebral amyloid angiopathy. Neurology 1985;35:625-631. (Pubitemid 15067013)
27. Yamada M, Itoh Y, Shintaku M, Kawamura J, Jensson O, Thorsteinsson L, Suematsu N, et al. Immune reactions associated with cerebral amyloid angiopathy. Stroke 1996;27:1155-1162. (Pubitemid 26226947)
28. Hawkes CA, McLaurin J. Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 2009;106:1261-1266.